跳至主要内容
临床试验/NCT02823132
NCT02823132已完成不适用

Study of the Level of Mannose Binding Lectin (MBL) as a Predictor of the Onset of a Invasive Fungal Infection (IFI) During Chemo-induced Aplasia in Patients With Acute Leukemia (AL)

Centre Hospitalier Universitaire Dijon1 个研究点 分布在 1 个国家目标入组 134 人开始时间: 2016年7月6日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
134
试验地点
1
主要终点
serum level of Mannose Binding Lectin (MBL) in patients with acute leukemia

研究概览

简要总结

The aim of this study is to investigate levels of a protein, mannose binding lectin, in patients with acute leukemia who develop or not an invasive fungal infection.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • Patients who have received an bone marrow PSC allograft (as such patients have a risk of aspergillosis, which appears in most cases after medullar recovery; they will not be included in the study).
  • Patients who have received an autologous PSC graf (as the duration of neutropenia is in most cases less than 10 days).
  • Patients whose neutropenia, retrospectively assessed, lasted less than 10 days.

结局指标

主要结局

serum level of Mannose Binding Lectin (MBL) in patients with acute leukemia

时间窗: 1st day of the period of aplasia

次要结局

  • Serum levels of MBL during an episode of aplasia for both groups of patients studied(Every day except Saturday and Sunday for roughly 3 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验